Novartis uses science-based innovation to address some of society’s most challenging healthcare issues. Novartis discovers and develops breakthrough treatments, and aims to lead in growing areas of healthcare where innovation can make a meaningful difference for patients and society.
Novartis offers a diversified portfolio of products in growing areas of healthcare. The Innovative Medicines Division has two business units: Novartis Pharmaceuticals, with patented treatments in the areas of Ophthalmology, Immunology and Dermatology, Neuroscience, Respiratory and Cardio-Metabolic, and Novartis Oncology, with treatments for cancers and rare diseases. Sandoz focuses on high-quality, affordable generics and biosimilars, and Alcon offers the world’s broadest portfolio of ophthalmic surgical technologies and vision care products to enhance sight and improve people’s lives.
Vas Narasimhan, CEO, Novartis AG
Tom Kendris, US Country President, US Country Head, Legal & President, Novartis Corporation
To Learn More